← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vidasym, Inc.
Sioux Falls, SD
$2,654,902
Total funding
6
Grants
Funding over time
peak $1.5M · FY2011–16$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,654,902 · 6
By mechanism
R44$1,480,983 · 1
R43$715,056 · 3
R41$458,863 · 2
Investigators at Vidasym, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel drug VS-105 for treatment of osteoporosis$1,480,983
R44 · FY2016 · AR
New drug VS-110 for treating inflammatory bowel diseases$299,216
R41 · FY2013 · DK
Novel Drug VS-105 for Treatment of Osteoporosis$278,579
R43 · FY2013 · AR
New drug Vida-5 for treating chronic kidney disease progression$219,123
R43 · FY2011 · DK
New drug VS-501 for treating hyperphosphatemia in chronic kidney disease$217,354
R43 · FY2012 · DK
Novel drug VS-105 for treatment of diabetic nephropathy$159,647
R41 · FY2012 · DK